Paper Details

  1. Home
  2. Paper Details

The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.

Author: AmesD, ChiuE, HallK, HarriganS, HassettA, MacfarlaneS, MastwykM, O'ConnorD W, OpieJ, RitchieC W

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This article discusses the use of atypical antipsychotics in the management of schizophrenia in the elderly. It notes that while they offer advantages over conventional antipsychotics, more research is needed to confirm their long-term efficacy and safety in this population.
Paper Details　
Original Abstract of the Article :
Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective, small, of short duration or...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/gps.862

データ提供：米国国立医学図書館（NLM）

Atypical Antipsychotics: Navigating the Sands of Schizophrenia Treatment in the Elderly

Schizophrenia is a complex mental health condition that can present unique challenges in older adults. This study examines the impact of switching from conventional antipsychotics to atypical antipsychotics, specifically risperidone or olanzapine, in elderly patients with schizophrenia. The researchers sought to evaluate the effects of this switch on extrapyramidal side effects, clinical symptoms, and quality of life.

Atypical Antipsychotics: A Potential Oasis for Elderly Schizophrenia Patients

The study suggests that switching to atypical antipsychotics may be beneficial for elderly patients with schizophrenia. While further research is needed to confirm these findings, the study indicates a potential for reduced motor disturbances and improved quality of life while maintaining similar efficacy compared to conventional antipsychotics.

Schizophrenia Treatment: A Personalized Approach

This study highlights the need for personalized treatment approaches for schizophrenia, particularly in elderly patients. The findings suggest that atypical antipsychotics may offer a more favorable side effect profile compared to conventional medications, potentially improving quality of life. Remember, finding the right path through the desert of mental health requires a careful consideration of individual needs and preferences, just as a camel chooses its route based on its own resources and the landscape.

Dr.Camel's Conclusion

Schizophrenia treatment, like a journey through the desert, requires careful navigation. This study suggests that atypical antipsychotics, like a refreshing oasis, may offer a more comfortable path for elderly patients. It's a reminder that finding the right treatment approach is crucial for navigating the complexities of mental health.

Date :
  1. Date Completed 2003-06-13
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

12766921

DOI: Digital Object Identifier

10.1002/gps.862

Related Literature

Article Analysis
・Side Effects of risperidone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.